ABEV Stock Price Today (April 2026) — Ambev S.A. Analysis & Key Metrics 2026-04-02
Ambev S.A. (ABEV) is trading at $3.16, up 6.39% today (as of April 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Consumer Defensive growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $3.10 (-1.9% upside).
- Volatility remains elevated (27.01% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (-8.20% YoY) alongside significant competitive pressures.
ABEV Stock Analysis: Key Metrics & Valuation (April 2026)
Concise, actionable data for investors
Ambev S.A. - Historical Price & Volume
Market Cap
Enterprise Value: $29.68B
P/E Ratio
Forward P/E: 13.81
Revenue Growth
Year over Year
Analyst Target
+-1.9% upside potential
Key Investor Questions About ABEV
What investors need to know before buying
Based on current market data, ABEV presents a neutral technical setup with challenging fundamentals.
- Technicals say: Neutral (RSI 55.99)
- Fundamentals say: Challenging (declining revenue trends)
ABEV's growth trajectory depends on its ability to expand within the Beverages - Brewers sector while managing margin pressures.
- Future growth will depend on performance in core Beverages - Brewers operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for ABEV investors include debt exposure and competitive dynamics in the Beverages - Brewers industry.
- $3.39B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Beverages - Brewers.
52-Week Trading Range
Over the past year, ABEV stock traded between $2.10 and $3.24—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 27.01% annualized volatility and β=0.28, the stock exhibits low sensitivity to market moves—making ABEV suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Stock Market Today, April 2: Ambev Slips as Analyst Ratings Temper Sentiment
On April 2, 2026, a fresh downgrade, elevated volume, and rising institutional interest put this brewer’s risk‑reward in sharp focus.
How The Ambev (BOVESPA:ABEV3) Story Is Shifting Toward Profitability Led Earnings Into 2026
Analysts have lifted their price target for Ambev to R$3.00, while the Fair Value estimate remains unchanged at R$15.09. The higher R$3.00 target is being framed as growing confidence that the company can translate profitability into more resilient earnings and cash generation as 2026 approaches, even though an Equal Weight rating remains in place. Read on to see how you can track this evolving narrative and what it could mean for your own view on Ambev. Stay updated as the Fair Value for...
Barclays Retains an Equal Weight Rating on Ambev S.A. (ABEV)
Ambev S.A. (NYSE:ABEV) is among the 12 Best Alcohol Stocks to Buy Right Now. On February 17, 2026, Barclays boosted Ambev S.A. (NYSE:ABEV)’s price objective to $3 from $2.50. The analyst retained an Equal Weight rating, noting a focus on profitability-led earnings and cash flow growth in 2026. On February 12, 2026, Ambev S.A. (NYSE:ABEV) […]
Ambev (ABEV) Reports 2025 Net Income of 16 Billion BRL and 70% Growth in B2B Marketplace GMV
Ambev (NYSE:ABEV) is one of the most undervalued penny stocks to buy right now. On February 12, Ambev reported its Q4 2025 financial results, where the company achieved a stated net income of nearly 16 billion BRL, with EPS increasing by 8.2% year-over-year. The company’s digital ecosystem saw robust performance, with the B2B marketplace GMV […]
Has Ambev (ABEV) Outpaced Other Consumer Staples Stocks This Year?
Here is how Ambev (ABEV) and Adecoagro (AGRO) have performed compared to their sector so far this year.
What Analysts Think Is Changing The Ambev (BOVESPA:ABEV3) Story On Profit And Cash
Ambev's fair value estimate has been updated from R$13.98 to R$14.81, with the discount rate moving from 18.16% to 18.09% and revenue growth assumptions shifting from 4.60% to 5.13% in R$ terms. These changes reflect fresh research that puts more weight on how effectively the company might turn future revenue into earnings and, crucially, into cash by 2026. Continue reading this article to see how you can keep on top of these evolving assumptions and what they could mean for the ongoing...
Is Ambev (ABEV) a Solid Growth Stock? 3 Reasons to Think "Yes"
Ambev (ABEV) possesses solid growth attributes, which could help it handily outperform the market.
Ambev (ABEV) Upgraded to Buy: Here's Why
Ambev (ABEV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are You Looking for a Top Momentum Pick? Why Ambev (ABEV) is a Great Choice
Does Ambev (ABEV) have what it takes to be a top stock pick for momentum investors? Let's find out.
ABEV or BF.B: Which Is the Better Value Stock Right Now?
ABEV vs. BF.B: Which Stock Is the Better Value Option?
Frequently Asked Questions
Common investor questions about Ambev S.A.
Ambev S.A. (ABEV) is currently trading at $3.16. The RSI (14-day) is at 56.0, indicating neutral territory. Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $3.10 implies 1.9% downside from current levels. Volatility is moderate at 27.0% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Ambev S.A. (ABEV): The trailing P/E ratio is 15.42, which is in line with broader market averages. The forward P/E is 13.81, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 2.09, above 2.0, suggesting the stock may be overvalued relative to its expected growth. Price-to-Book is 2.70. Price-to-Sales is 0.52. Valuation should be compared to Beverages - Brewers industry peers for context, as different sectors trade at different multiples.
Based on 10 analysts covering ABEV, the consensus price target is $3.10. This represents a 1.9% downside from the current price of $3.16. The range spans from a low target of $2.35 to a high target of $4.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Ambev S.A. (ABEV) pays a dividend with a current yield of approximately 10.00%. The annualized dividend rate is $1.11 per share. The payout ratio is 113.2%, which exceeds 100%—this means the company is paying out more than it earns, which may not be sustainable long-term. The most recent ex-dividend date was 2025-12-22.
Key risks for Ambev S.A. (ABEV) investors include: 1. Moderate volatility (27.0% annualized)—price swings are notable. 2. Declining revenue (-8.2% YoY), indicating potential business headwinds. 3. Unsustainable dividend payout ratio (113%) could lead to a dividend cut. 4. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 5. Beverages - Brewers sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Ambev S.A.'s (ABEV) current debt and financial health profile: Total debt stands at $3.39B. The debt-to-equity ratio is 3.82, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 0.96, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.66. The company holds $20.32B in cash and equivalents. Free cash flow is positive at $12.53B, providing a cushion for debt servicing and shareholder returns.